Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-09-13 Sale | 2024-10-24 4:15 pm | Janux Therapeutics Inc. | JANX | Lichter Jay 10% Owner | 3,815 | $46.68 | $178,084 | 6,618,252 (Indirect Direct) | View |
| 2024-10-16 Sale | 2024-10-18 6:51 pm | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 1,673,128 | $46.3 | $77,472,371 | 4,281,533 (Indirect Direct) | View |
| 2024-09-26 Sale | 2024-09-30 8:49 pm | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 307,779 | $46.96 | $14,452,394 | 3,005,777 (Indirect Direct) | View |
| 2024-09-10 Sale | 2024-09-12 8:42 pm | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 451,091 | $46.89 | $21,153,619 | 5,987,589 (Indirect Direct) | View |
| 2024-09-06 Sale | 2024-09-10 5:02 pm | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 242,182 | $42 | $10,172,364 | 3,297,625 (Indirect Direct) | View |
| 2024-06-03 Sale | 2024-06-05 7:25 pm | Janux Therapeutics Inc. | JANX | Lichter Jay Director 10% Owner | 1,500,000 | $54.75 | $82,125,000 | 3,344,601 (Indirect Direct) | View |
| 2023-11-13 Purchase | 2023-11-15 4:46 pm | Janux Therapeutics Inc. | JANX | Lichter Jay Director 10% Owner | 849,854 | $5.87 | $4,988,643 | 9,716,563 (Indirect) | View |
| 2021-06-15 Purchase | 2021-06-16 6:05 pm | Janux Therapeutics Inc. | JANX | Lichter Jay Director 10% Owner | 629,411 | $17 | $10,699,987 | 4,479,492 (Indirect) | View |
| 2021-03-03 Sale | 2021-03-03 8:06 pm | OTONOMY INC. | OTIC | Lichter Jay Director | 321,180 | $2.698 | $866,544 | 0 (Indirect) | View |
| 2021-02-26 Sale | 2021-03-02 7:51 pm | OTONOMY INC. | OTIC | Lichter Jay Director | 893,828 | $2.8651 | $2,560,930 | 113,935 (Indirect) | View |
| 2021-02-23 Sale | 2021-02-25 9:56 pm | OTONOMY INC. | OTIC | Lichter Jay Director | 1,082,353 | $2.9507 | $3,193,663 | 431,015 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-13 Exercise | 2024-10-24 4:15 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Lichter Jay 10% Owner | 778 | $10.73 | 6,618,252 (Direct) | View |
| 2024-09-13 Exercise | 2024-10-24 4:15 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Lichter Jay 10% Owner | 391 | $39.8 | 6,618,252 (Direct) | View |
| 2024-09-13 Exercise | 2024-10-24 4:15 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Lichter Jay 10% Owner | 1,868 | $17 | 6,618,252 (Direct) | View |
| 2024-09-13 Exercise | 2024-10-24 4:15 pm | N/A 2027-07-19 | Janux Therapeutics Inc. | JANX | Lichter Jay 10% Owner | 3,815 | $0 | 6,618,252 (Direct) | View |
| 2024-09-13 Exercise | 2024-10-24 4:15 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Lichter Jay 10% Owner | 778 | $13.22 | 6,618,252 (Direct) | View |
| 2024-10-16 Exercise | 2024-10-18 6:51 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 2,418 | $10.73 | 4,281,533 (Direct) | View |
| 2024-10-16 Exercise | 2024-10-18 6:51 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 1,644 | $39.8 | 4,281,533 (Direct) | View |
| 2024-10-16 Exercise | 2024-10-18 6:51 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 5,804 | $17 | 4,281,533 (Direct) | View |
| 2024-10-16 Exercise | 2024-10-18 6:51 pm | N/A 2027-07-19 | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 12,284 | $0 | 4,281,533 (Direct) | View |
| 2024-10-16 Exercise | 2024-10-18 6:51 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 2,418 | $13.22 | 4,281,533 (Direct) | View |
| 2024-09-27 Exercise | 2024-09-30 8:49 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 526 | $10.73 | 3,005,777 (Direct) | View |
| 2024-09-27 Exercise | 2024-09-30 8:49 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 357 | $39.8 | 3,005,777 (Direct) | View |
| 2024-09-27 Exercise | 2024-09-30 8:49 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 1,262 | $17 | 3,005,777 (Direct) | View |
| 2024-09-27 Exercise | 2024-09-30 8:49 pm | N/A 2027-07-19 | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 2,671 | $0 | 3,005,777 (Direct) | View |
| 2024-09-27 Exercise | 2024-09-30 8:49 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 526 | $13.22 | 3,005,777 (Direct) | View |
| 2024-09-09 Exercise | 2024-09-10 5:02 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 414 | $10.73 | 3,297,625 (Direct) | View |
| 2024-09-09 Exercise | 2024-09-10 5:02 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 277 | $39.8 | 3,297,625 (Direct) | View |
| 2024-09-09 Exercise | 2024-09-10 5:02 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 994 | $17 | 3,297,625 (Direct) | View |
| 2024-09-09 Exercise | 2024-09-10 5:02 pm | N/A 2027-07-19 | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 2,099 | $0 | 3,297,625 (Direct) | View |
| 2024-09-09 Exercise | 2024-09-10 5:02 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. Lichter Jay 10% Owner | 414 | $13.22 | 3,297,625 (Direct) | View |
| 2024-06-26 Option Award | 2024-06-28 4:30 pm | N/A 2034-06-25 | Janux Therapeutics Inc. | JANX | Lichter Jay Director 10% Owner | 10,850 | $0 | 7,260,340 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 5:10 pm | N/A 2033-06-13 | Janux Therapeutics Inc. | JANX | Lichter Jay Director 10% Owner | 12,500 | $0 | 12,500 (Direct) | View |
| 2022-06-21 Option Award | 2022-06-23 4:34 pm | N/A 2032-06-20 | OTONOMY INC. | OTIC | Lichter Jay Director | 27,500 | $0 | 27,500 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 4:31 pm | N/A 2032-06-13 | Janux Therapeutics Inc. | JANX | Lichter Jay Director 10% Owner | 12,500 | $0 | 12,500 (Direct) | View |
| 2021-06-22 Option Award | 2021-06-24 5:02 pm | N/A 2031-06-21 | OTONOMY INC. | OTIC | Lichter Jay Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2021-06-15 Conversion | 2021-06-16 6:05 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Lichter Jay Director 10% Owner | 14,325,514 | $0 | 4,479,492 (Indirect) | View |
| 2021-06-10 Option Award | 2021-06-14 5:37 pm | N/A 2031-06-09 | Janux Therapeutics Inc. | JANX | Lichter Jay Director 10% Owner | 30,000 | $0 | 30,000 (Direct) | View |
Ownership | 2021-06-10 7:12 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Lichter Jay Director 10% Owner | 0 | $0 | 8,237,298 (Indirect) | View |
| 2020-06-23 Option Award | 2020-06-25 5:06 pm | N/A 2030-06-22 | OTONOMY INC. | OTIC | Lichter Jay Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2020-01-23 Equity Swap | 2020-01-24 6:28 pm | N/A N/A | Synthorx Inc. | THOR | Lichter Jay Director | 2,280,653 | $68 | 0 (Indirect) | View |
| 2020-01-23 Disposition | 2020-01-24 6:28 pm | N/A 2028-12-05 | Synthorx Inc. | THOR | Lichter Jay Director | 30,000 | $57 | 0 (Direct) | View |
| 2020-01-23 Disposition | 2020-01-24 6:28 pm | N/A 2029-06-06 | Synthorx Inc. | THOR | Lichter Jay Director | 15,335 | $55.6 | 0 (Direct) | View |
| 2020-01-14 Other | 2020-01-16 4:24 pm | N/A N/A | Synthorx Inc. | THOR | Lichter Jay Director | 5,047,363 | $0 | 7,178,016 (Indirect) | View |